Back to top
more

CareCloud (CCLD)

(Real Time Quote from BATS)

$2.48 USD

2.48
239,360

-0.18 (-6.77%)

Updated Aug 28, 2026 10:06 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (85 out of 248)

Industry: Medical Info Systems

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

CapsoVision Submits FDA 510(k) for AI-Assisted Module in CapsoCam Plus

by Zacks Equity Research

CV seeks FDA clearance to add AI-based reading to CapsoCam Plus to boost diagnostic accuracy and streamline reviews.

Zacks Equity Research

KRMD Submits 510(k) to Use FreedomEDGE System With Oncology Biologic

by Zacks Equity Research

KORU Medical filed a 510(k) to use FreedomEDGE for subcutaneous PHESGO delivery, expanding into oncology and simplifying breast cancer care.

Zacks Equity Research

Should Value Investors Buy CareCloud (CCLD) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

FLGT to Acquire Bako & StrataDx Assets to Expand Pathology Platform

by Zacks Equity Research

Fulgent is set to buy Bako Diagnostics assets and StrataDx for $55.5M, expanding into anatomic pathology and dermatopathology to scale lab services.

Zacks Equity Research

Here's Why You Should Retain INSP Stock in Your Portfolio Now

by Zacks Equity Research

INSP's Inspire V gains traction with strong clinical data, improving reimbursement visibility and cost control, even as inventory and GLP-1 headwinds persist.

Zacks Equity Research

Revvity Advances AI-Driven Scientific Discovery With Signals Xynthetica

by Zacks Equity Research

RVTY unveils Signals Xynthetica, an AI-augmented design platform that links predictive models with real lab data to speed discovery.

Indrajit Bandyopadhyay headshot

3 MedTech Innovators Shaping Healthcare in 2026: AVAH, INGN & CCLD

by Indrajit Bandyopadhyay

AVAH, INGN & CCLD show how home care, portable oxygen tech and cloud healthcare IT are reshaping care delivery and efficiency into 2026.

Zacks Equity Research

Here's Why You Should Retain CLOV Stock in Your Portfolio Now

by Zacks Equity Research

Clover Health shows strong membership growth, rising revenues and sustained EBITDA gains from Clover Assistant, though near-term margin pressure remains a risk.

Zacks Equity Research

Should Value Investors Buy CareCloud (CCLD) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Are Medical Stocks Lagging CareCloud (CCLD) This Year?

by Zacks Equity Research

Here is how CareCloud, Inc. (CCLD) and Alvotech (ALVO) have performed compared to their sector so far this year.